Related Experiment Video
Updated: Feb 13, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Interest in Long-Acting PrEP by Methamphetamine Use Among Men Who Have Sex with Men in Four Western US Cities
Vanessa M McMahan1,2,3, Courtney Moreno4, Alia Al-Tayyib5
1Harvard Medical School, Boston, MA, USA. Vanessa_McMahan@hphci.harvard.edu.
Abstract:
Methamphetamine use is a driver of HIV among men who have sex with men (MSM) and is associated with suboptimal adherence to daily, oral PrEP. Long-acting PrEP may be a promising alternative. We analyzed data from the 2023 National HIV Behavioral Surveillance survey in four western cities to assess interest in long-acting PrEP among HIV-negative MSM participants. Of 1,450 participants, 7% used methamphetamine in the past 12 months. Two-thirds were interested in long-acting PrEP (68%); with no difference in interest (χ2 = 1.4, p = 0.24) or prior PrEP use (χ2 = 0.56, p = 0.46) by methamphetamine use. A larger proportion of participants unaware of PrEP had used methamphetamine (20% vs. 7%, χ2 = 10.7, p < 0.01). Among those interested, a plurality preferred biannual injection (47%). We found high interest in long-acting PrEP and similar PrEP use rates, but lower awareness, among participants who used methamphetamine. However, our sample may not have been representative of those with higher-risk methamphetamine use.
Insights
Interest in long-acting pre-exposure prophylaxis (PrEP) is high among men who have sex with men (MSM). Methamphetamine users showed similar interest and use but lower awareness of PrEP options.
Area of Science:
- Public Health
- Infectious Disease Prevention
- Sexual Health
Background:
- Methamphetamine use is a significant factor in HIV transmission among men who have sex with men (MSM).
- Suboptimal adherence to daily oral pre-exposure prophylaxis (PrEP) is common among methamphetamine-using MSM.
- Long-acting PrEP presents a potential alternative to daily oral PrEP.
Purpose of the Study:
- To assess interest in long-acting PrEP among HIV-negative MSM.
- To compare interest and PrEP awareness between methamphetamine users and non-users within this population.
Main Methods:
- Analysis of data from the 2023 National HIV Behavioral Surveillance survey.
- Inclusion of 1,450 HIV-negative MSM participants from four western cities.
- Assessment of methamphetamine use in the past 12 months and interest in long-acting PrEP.
Main Results:
- Two-thirds (68%) of participants expressed interest in long-acting PrEP.
- No significant differences in interest or prior PrEP use were observed between methamphetamine users and non-users.
- Participants unaware of PrEP were more likely to have used methamphetamine (20% vs. 7%).
- Among interested individuals, biannual injection was the preferred method (47%).
Conclusions:
- High interest in long-acting PrEP exists among MSM, including those who use methamphetamine.
- Methamphetamine users demonstrated similar PrEP interest and use but lower awareness compared to non-users.
- Targeted awareness campaigns may be needed for methamphetamine-using MSM regarding PrEP options.
Related Concept Videos
Western Blotting
The technique begins with separating proteins from the sample using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by protein transfer, immunoblotting, and finally, protein detection.
Sex-linked Disorders
Forces Acting on Chromosomes
Microtubules and motor proteins exert two types of forces on...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drugs Acting on Autonomic Ganglia: Blockers

